Literature DB >> 28781161

Prevalence of Metabolically Healthy Obesity (MHO) and its relation with incidence of metabolic syndrome, hypertension and type 2 Diabetes amongst individuals aged over 20 years in Ahvaz: A 5 Year cohort Study (2009-2014).

Seyed Mahmoud Latifi1, Majid Karandish2, Hajieh Shahbazian3, Jalaly Mohammad Taha4, Bahman Cheraghian5, Mitra Moradi6.   

Abstract

BACKGROUND: Today, obesity epidemic is one of the major health problems of the present century. One of the phenotypes of obesity is metabolically healthy obesity. It seems that these obese individuals suffer less from cardiovascular disease and metabolically unhealthy obesity. This study aimed to investigate the prevalence of metabolically healthy obesity (MHO) and its relationship with incidence of metabolic syndrome, diabetes and hypertension in individuals over 20 years in the city of Ahvaz.
MATERIALS AND METHODS: This study was a 5-year cohort study, which was conducted on adults between years 2009 to 2014.Participants who were randomly selected from individuals covered by the health centers in the city of Ahvaz in baseline population, were again recalled by these centers. The subjects completed the question aires, and anthropometric measurements and blood samples were prepared for performing tests based on Phase 1.
RESULTS: A total of 591 individuals Participated in this study, 281 (47.5%) were males and 310 (52.5%) females with mean age of 42.2±13.3 years. The prevalence of MHO was 19.5% in the baseline population. The cumulative incidence of metabolic syndrome, diabetes and hypertension in MHO individuals were 29.6%, 24.3% and 13%, respectively.
CONCLUSION: The prevalence of MHO was 19.5% in the baseline population. There was a specific relationship between MHO and incidence of metabolic syndrome and diabetes; however, there was a less significant relationship between MHO and hypertension.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Incidence; Metabolically healthy obesity (MHO); Prevalence

Mesh:

Year:  2017        PMID: 28781161     DOI: 10.1016/j.dsx.2017.07.036

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  10 in total

1.  Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Hadis Mozaffari; Sakineh Shab-Bidar; Alireza Milajerdi; Kurosh Djafarian
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

2.  Prevalence and predictors of metabolically healthy obesity in severely obese Asian children.

Authors:  Delicia Shu Qin Ooi; Siong Gim Ong; Owen Ming Hao Lee; Yiong Huak Chan; Yvonne Yijuan Lim; Cindy Wei Li Ho; Veronica Tay; K Vijaya; Kah Yin Loke; Andrew Anjian Sng; Yung Seng Lee
Journal:  Pediatr Res       Date:  2022-02-07       Impact factor: 3.953

3.  Abnormal Obesity Phenotype Is Associated with Reduced eGFR among Diabetes Mellitus and Hypertensive Patients in a Peri-Urban Community in Ghana.

Authors:  Richard K D Ephraim; Frederick Ahordzor; Kwame Kumi Asare; Evans Duah; Ibrahim W Naveh-Fio; Grace Essuman; Justice Afrifa
Journal:  Int J Nephrol       Date:  2022-05-29

4.  Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?

Authors:  Ligiane Marques Loureiro; Suzane Lessa; Rodrigo Mendes; Sílvia Pereira; Carlos José Saboya; Andrea Ramalho
Journal:  Nutrients       Date:  2019-09-06       Impact factor: 5.717

5.  Clinic, Anthropometric And Metabolic Changes In Adults With Class III Obesity Classified As Metabolically Healthy And Metabolically Unhealthy.

Authors:  Ligiane M Loureiro; Adryana Cordeiro; Rodrigo Mendes; Mariana Luna; Sílvia Pereira; Carlos J Saboya; Andrea Ramalho
Journal:  Diabetes Metab Syndr Obes       Date:  2019-11-27       Impact factor: 3.168

6.  Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese.

Authors:  Shasha Yu; Xiaofan Guo; Guang Xiao Li; Hongmei Yang; Liqiang Zheng; Yingxian Sun
Journal:  BMC Nephrol       Date:  2020-11-24       Impact factor: 2.388

Review 7.  Metabolically healthy obesity: Is it really healthy for type 2 diabetes mellitus?

Authors:  Qi Wu; Ming-Feng Xia; Xin Gao
Journal:  World J Diabetes       Date:  2022-02-15

8.  A novel resveratrol analog PA19 attenuates obesity‑induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration.

Authors:  Wenxin Zhang; Hongjin Chen; Chuchu Sun; Beibei Wu; Bin Bai; Hui Liu; Xiaoou Shan; Guang Liang; Yali Zhang
Journal:  Mol Med Rep       Date:  2019-04-12       Impact factor: 2.952

9.  Prevalence and clinical characteristics of metabolically unhealthy obesity in an Iranian adult population.

Authors:  Karamatollah Rahmanian; Mohammad Shojaei; Abdolreza Sotoodeh Jahromi
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-13       Impact factor: 3.168

Review 10.  Risk of type 2 diabetes in metabolically healthy people in different categories of body mass index: an updated network meta-analysis of prospective cohort studies.

Authors:  Somayeh Tajik; Atieh Mirzababaei; Ehsan Ghaedi; Hamed Kord-Varkaneh; Khadijeh Mirzaei
Journal:  J Cardiovasc Thorac Res       Date:  2019-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.